Advertisement
Two new studies add insights and home in on therapeutic targets
Celecoxib is noninferior to naproxen and ibuprofen in cardiac safety
Trial stopped early after evacetrapib fails to budge event rate
Findings from large cohort up the stakes for preventive cardiology care
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement